Social networks
305Activities
Technologies
Entity types
Location
Kamenice 771/34, 625 00 Brno-Brno-Bohunice, Czechia
Brno
Czechia
Employees
Scale: 2-10
Estimated: 7
Engaged corporates
0Added in Motherbase
7 months, 1 week agoNovel Treatment of Leukemias, Lymphomas and Solid Tumors with Highly Potent and Selective Inhibitors of CK1 Kinases
The mission of CasInvent Pharma is to bring new therapeutic options for the treatment of selected leukemias to market. We are developing highly selective small molecule inhibitors of casein kinase I (CK1), and our main development program is focused on the identification of new drugs for the treatment of acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL).
CasInvent Pharma was established in 2020 as a spin-off company of Masaryk University in cooperation with the investment partner i&i Prague.
Highly Potent and Selective Inhibitors of CK1 Kinases for the Treatment of Leukaemias, Lymphomas and Solid Tumors